Lee Biosolutions Inc. Expands To Larger Campus In Maryland Heights, Missouri
07/02/2014
The firm is a key manufacturer of high purity enzymes and related proteins that include tumor markers, cardiac markers, specialty diagnostic proteins for immunological diseases and biomarkers. The company is known internationally for developing some of the most successful formulations for research, diagnostic and therapeutic markets.
Company officials said the need for a new space is in response to its rising growth into new markets and increased demand for its products. Its new campus was previously home to KV Pharmaceuticals. The Increased analytical lab space is needed for Lee Bio's increased growth for bioanalytical research and development projects and its ever expanding bulk manufacturing requirements. The added capacity and resources will help the company achieve its projected growth through 2017.
Burton Lee, President/CEO said ,"With the rapid growth we have seen over the last few years, our current facility was not able to keep up with demand. The new building supports our strategic objective to further expand our product lines, increase our capacity on key contract manufacturing products requiring larger cGMP processing clean rooms and to create operational efficiencies to meet our clients requirements." The company plans on doubling its payroll by 2016.
Most Read
-
-
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Q3 2019
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019
-
A Heightened Focus on Reshoring
Q3 2020
-
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
Q3 2020
-
COVID-19 and Site Selection in the Near and Long Term
Q2 2020
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020